MY ACCOUNT | NEWSLETTER |

Serum C-reactive protein concentrations in dogs with epilepsy


C-reactive protein (CRP) is an acute-phase protein produced by the liver during systemic inflammation. In humans, some epilepsies are associated with increased serum CRP (sCRP) concentrations, but this has yet to be proven in veterinary studies. Dogs with structural epilepsy (SE) and normal interictal neurological examination are hard to distinguish from dogs with idiopathic epilepsy (IE) without the use of advanced imaging. Therefore, the aim of this retrospective observational cohort study was to investigate if there were increases in sCRP in dogs with epilepsy and to compare the sCRP concentrations between dogs with SE and dogs with IE

Dogs with SE and IE from a referral hospital population were enrolled. The Mann-Whitney test was used to compare the sCRP concentrations within 24 hours of the last epileptic seizure between dogs with SE or IE.

The population study included 8 dogs with SE and 12 dogs with IE. Dogs with SE had higher sCRP concentrations than dogs with IE (8.9 [range <2.2-53.2] mg/L vs. <2.2 [range <2.2-6.9] mg/L; p = 0.043). Five of the eight (62%) dogs with SE had an sCRP concentration above the reference interval, compared with none of the 12 dogs with IE.

In conclusion, this study found that sCRP concentrations were higher in this cohort of dogs with SE than in those with IE. Other inflammatory causes were also not exclusively ruled out, although further clinical investigations were not indicated. Further studies with larger cohorts of dogs are warranted to validate if sCRP can be used as an additional biomarker for SE. 



“Serum C-reactive protein concentrations in dogs with structural and idiopathic epilepsy”. Elizabeth K Mahon, et al. Vet Rec. 2023 Jul 28;e3211.  doi: 10.1002/vetr.3211. 

Source: https://bvajournals.onlinelibrary.wiley.com/doi/abs/10.1002/vetr.3211


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Evaluation of 3D additively manufactured canine brain models for teaching veterinary neuroanatomy

Like0
Dislike0

Reasons for whole carcass condemnations of cattle in the United States and implications for producer education and veterinary intervention

Like0
Dislike0

A New Penn Vet Clinic Brings Support and Hope for Dogs with Retinal Disease

Like0
Dislike0

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic

Like0
Dislike0

Cooperation in regional innovation networks among small and medium enterprises: Case study of a veterinary pharmaceutical company in Jalisco, Mexico

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top